Chemistry Reference
In-Depth Information
46. Wischmeyer PE, Riehm J, Singleton KD, Ren H, Musch MW, and Kahana M, et al.
Glutamine attenuates tumor necrosis factor-α release and enhances heat shock protein
72 in human peripheral blood mononuclear cells.
Nutrition
2003;19:1-6.
47. Hallert C, Björck I, Nyman M, Pousette A, Granno C, and Svensson H. Increasing fecal
butyrate in ulcerative colitis patients by diet: Controlled pilot study.
Inflamm Bowel Dis
2003;9:116-121.
48. Lührs H, Gerke T, Müller JG, Melcher R, Schauber J, and Boxberge F et al. Butyrate
inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative
colitis.
Scand J Gastroenterol
2002;37:458-466.
49. Welters CF, Heineman E, Thunnissens FB, van den Bogaard AE, and Soeters PB, Baeten
CG.. Effect of dietary inulin supplementation on inflammation of pouch mucosa in
patients with an ileal pouch-anal anastomosis.
Dis Colon Rectum
2002;45:621-627.
50. Murch SH. The immunologic basis for intestinal food allergy.
Curr Opin Gastroenterol
2000;15:552-557.
51. Bommelaer G, Dorval E, and Denis PH et al. Prevalence of irritable bowel syn-
drome in the French population according to Rome I criteria.
Gastroenterol Clin Biol
2002;26:11218-1123.
52. Wilhelm SM, Brubaker CM,Varcak EA, and Kale-Pradhan PB. Effectiveness of probiotics
in the treatment of irritable bowel syndrome.
Pharmacotherapy
2008;28(4):496-505.
53. MacFarlane S, MacFarlane GT, and Cummings JH. Review article: Prebiotics in the
gastrointestinal tract.
Aliment Pharmacol Ther
2006;24:701-714.
54. Spiller P. Review article: Probiotics and prebiotics in irritable bowel syndrome (IBS).
Aliment Pharmacol Ther
2008 E-pub doi: 10.1111/j.1365-2036.2008.03750.
55. Seifert S and Watzl B. Prebiotics and the immune system: Review of experimental and
human data. In Gibson G and Roberfroid M (Eds.)
Handbook in Prebiotics
. CRC Press,
Boca Raton, FL, 2008.
56. Lindsay JO, Whelan K, and Stagg AJ et al. Clinical, microbiological, and immuno-
logical effects disease of fructo-oligosaccharide in patients with Crohn's disease.
Gut
2006;55:348-355.
57. Huertas-Ceballos A, Logan S, Bennett C, and Macarthur C. Dietary interventions for
recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
Cochrane Database Syst Rev
2008 Jan 23;(1):CD003019.
58. Parisi GC, Zilli M, and Miani MP, et al. High-fiber diet supplementation in patients
with irritable bowel syndrome (IBS): A multicenter, randomized, open trial compari-
son between wheat bran diet and partially hydrolyzed guar gum (PHGG).
Dig Dis Sci
2002;47:1697-1704.
59. Akbar A, Yiangou Y, and Facer P et al. Increased capsaicin receptor TRPV1 expressing
sensory fibres in irritable bowel syndrome and their correlation with abdominal pain.
Gut
2008 Feb 5 [Epub ahead of print].
60. de Felippe Junior J, da Rocha e Silva Junior M, Maciel FM, Soares Ade M, and Mendes
NF. Infection prevention in patients with severe multiple trauma with the immunomodu-
lator beta 1-3 polyglucose (glucan).
Surg Gynecol Obstet
1993;177:383-388.
61. Caparros T, Lopez J, and Grau T. Early enteral nutrition in critically ill patients with
a high-protein diet enriched with arginine, fiber, and antioxidants compared with a
standard high-protein diet. The effect on nosocomial infections and outcome.
JPEN J
Parenter Enteral Nutr
2001;25:299-308.
62. Wegkamp A, Starrenburg M, de Vos WM, Hugenholtz J, and Sybesma W. Transformation
of folate-consuming
Lactobacillus gasseri
into a folate producer.
Appl Environ Microbiol
2004;70:3146-3148.
